

Mentat
| Product dosage: 60caps | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 2 | $28.00 | $56.00 (0%) | 🛒 Add to cart |
| 3 | $26.33 | $84.00 $79.00 (6%) | 🛒 Add to cart |
| 4 | $25.25 | $112.00 $101.00 (10%) | 🛒 Add to cart |
| 5 | $24.60 | $140.00 $123.00 (12%) | 🛒 Add to cart |
| 6 | $24.33 | $168.00 $146.00 (13%) | 🛒 Add to cart |
| 7 | $24.00 | $196.00 $168.00 (14%) | 🛒 Add to cart |
| 8 | $23.88 | $224.00 $191.00 (15%) | 🛒 Add to cart |
| 9 | $23.67 | $252.00 $213.00 (15%) | 🛒 Add to cart |
| 10 | $23.60
Best per bottle | $280.00 $236.00 (16%) | 🛒 Add to cart |
Similar products

More info:
Metformin: The Cornerstone of Type 2 Diabetes Management
Metformin hydrochloride is a first-line, biguanide-class oral antihyperglycemic agent, widely recognized as the foundational pharmacological therapy for the management of type 2 diabetes mellitus (T2DM). Its primary mechanism of action involves decreasing hepatic glucose production (gluconeogenesis) and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike many other antidiabetic agents, metformin is not associated with weight gain and carries a low risk of hypoglycemia when used as monotherapy, making it a preferred initial choice for clinicians worldwide.
Natural Joint Support with Shallaki Extract for Enhanced Mobility
Shallaki, derived from the resin of the Boswellia serrata tree, is a time-honored botanical extract with a robust profile in supporting joint health and inflammatory response. Known in Ayurvedic medicine as Indian frankincense, it contains active boswellic acids that target key pathways in the body’s inflammatory processes. This product card provides a comprehensive, evidence-based overview for healthcare professionals and informed consumers considering shallaki for therapeutic use. Features Standardized extract containing a minimum of 65% boswellic acids for consistent potency Sourced from sustainably harvested Boswellia serrata resin in accordance with traditional practices Produced in a cGMP-certified facility with third-party verification for purity and heavy metal screening Formulated without common allergens: gluten-free, soy-free, and non-GMO Available in 500mg vegetarian capsules for precise dosing and optimal bioavailability Benefits Supports healthy joint function and comfort by modulating inflammatory mediators like 5-LOX Promotes improved mobility and flexibility in individuals with age-related joint concerns Contributes to the management of occasional stiffness and discomfort associated with physical activity Aids in maintaining cartilage integrity through inhibition of matrix metalloproteinases Provides a natural, well-tolerated alternative to conventional support strategies Supports overall musculoskeletal wellness as part of a holistic health regimen Common use Shallaki is primarily utilized for its supportive role in musculoskeletal conditions, particularly those involving inflammatory components.
Rumalaya Forte: Advanced Herbal Support for Joint and Musculoskeletal Health
Rumalaya Forte is a clinically-formulated polyherbal tablet designed to provide comprehensive support for joint function, mobility, and musculoskeletal comfort. As an expert-recommended supplement, it combines the synergistic actions of multiple well-researched botanical extracts to address inflammation, stiffness, and discomfort associated with various musculoskeletal conditions. Its dual-action approach not only helps manage symptoms but also supports long-term joint integrity, making it a preferred choice among healthcare practitioners and patients seeking a natural, evidence-based solution.
Urispas: Effective Relief for Bladder Spasms and Urinary Discomfort
Urispas (flavoxate HCl) is a prescription antispasmodic medication specifically formulated to target and relieve symptoms associated with urinary tract conditions. It works by relaxing the smooth muscle of the urinary bladder, thereby reducing frequency, urgency, and painful spasms. Clinically proven and trusted by urologists, it provides targeted symptomatic relief for patients experiencing discomfort from various urologic diagnoses, improving quality of life and daily comfort. Features Active ingredient: Flavoxate Hydrochloride 100 mg Prescription-only antispasmodic agent Tablet form for oral administration Musculotropic action with direct effect on detrusor muscle No anticholinergic activity at therapeutic doses Manufactured under strict pharmaceutical quality standards Benefits Reduces urinary urgency and frequency, allowing for normalized voiding patterns Alleviates suprapubic pain and dysuria associated with bladder spasms Decreases nocturia, supporting uninterrupted sleep Improves overall comfort and daily functioning in patients with urologic conditions Provides targeted action with minimal effect on other smooth muscles Supports bladder rehabilitation and comfort during diagnostic procedures Common use Urispas is commonly prescribed for the symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence associated with urologic conditions such as cystitis, prostatitis, urethritis, and urethrocystitis/urethrotrigonitis.
Actoplus Met: Dual-Action Control for Type 2 Diabetes
Actoplus Met combines two proven antihyperglycemic agents, pioglitazone and metformin, into a single tablet to provide comprehensive glycemic management for adults with type 2 diabetes mellitus. This fixed-dose combination therapy targets two key pathophysiological defects of the disease—insulin resistance and hepatic glucose overproduction—offering a synergistic approach to lower both fasting and postprandial blood glucose levels. By addressing multiple mechanisms simultaneously, it can simplify treatment regimens and improve adherence, which is critical for long-term metabolic control and reducing the risk of diabetes-related complications.
Actos: Advanced Type 2 Diabetes Management with Pioglitazone
Actos (pioglitazone hydrochloride) is a thiazolidinedione-class oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. By enhancing insulin sensitivity in peripheral tissues, it addresses core pathophysiological defects associated with the disease. This medication is designed for long-term management, helping to stabilize blood glucose levels and potentially reduce the risk of diabetic complications when used as part of a comprehensive treatment plan under medical supervision.
Amaryl: Advanced Glycemic Control for Type 2 Diabetes
Amaryl (glimepiride) is a second-generation sulfonylurea oral antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It functions primarily by stimulating insulin secretion from the pancreatic beta cells. This medication is recognized for its once-daily dosing convenience and its role in comprehensive diabetes management strategies, often used both as monotherapy and in combination with other antihyperglycemic agents when needed.
Baclofen: Effective Muscle Spasticity Relief for Enhanced Mobility
Baclofen is a centrally-acting skeletal muscle relaxant primarily indicated for the management of muscle spasticity. It functions as a gamma-aminobutyric acid (GABA) derivative, specifically targeting GABA-B receptors within the spinal cord to inhibit monosynaptic and polysynaptic reflex transmission. This pharmacological action results in reduced muscle tone and frequency of spasms, offering significant symptomatic relief for patients with neurological conditions. Clinicians value baclofen for its targeted mechanism and well-established efficacy profile in both oral and intrathecal formulations.
Baclosign: Targeted Spasticity Relief with Precision Muscle Relaxation
Baclosign (baclofen) is a centrally acting skeletal muscle relaxant specifically formulated for the management of spasticity resulting from multiple sclerosis, spinal cord injuries, and other neurological diseases. It operates as a gamma-aminobutyric acid (GABA) agonist, primarily exerting its effect at the spinal cord level to inhibit monosynaptic and polysynaptic reflex transmission. This targeted mechanism reduces the frequency and amplitude of muscle spasms, alleviates associated pain, and improves range of motion, thereby facilitating daily activities and therapeutic regimens.